TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $653,000 | -18.4% | 47,877 | -1.9% | 0.00% | – |
| Q3 2021 | $800,000 | -7.9% | 48,823 | -5.4% | 0.00% | – |
| Q2 2021 | $869,000 | -25.2% | 51,634 | -18.9% | 0.00% | – |
| Q1 2021 | $1,162,000 | +7.0% | 63,633 | +6.6% | 0.00% | – |
| Q4 2020 | $1,086,000 | -2.1% | 59,700 | -3.9% | 0.00% | – |
| Q3 2020 | $1,109,000 | -2.2% | 62,152 | -1.5% | 0.00% | – |
| Q2 2020 | $1,134,000 | +53.9% | 63,075 | +30.0% | 0.00% | – |
| Q1 2020 | $737,000 | -62.7% | 48,527 | -51.5% | 0.00% | – |
| Q4 2019 | $1,974,000 | +14.4% | 100,056 | -0.3% | 0.00% | – |
| Q3 2019 | $1,726,000 | -5.3% | 100,358 | -2.5% | 0.00% | – |
| Q2 2019 | $1,822,000 | -5.6% | 102,918 | +8.5% | 0.00% | – |
| Q1 2019 | $1,931,000 | +251.7% | 94,816 | +190.4% | 0.00% | – |
| Q4 2018 | $549,000 | – | 32,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |